Details
Title
Balanitis Xerotica Obliterans: an underestimated cause of secondary phimosisJournal title
Folia Medica CracoviensiaYearbook
2021Volume
Vol. 61Issue
No 4Affiliation
Gkalonaki, Ioanna : First Department of Pediatric Surgery, Aristotle University of Thessaloniki Greece, General Hospital “G.Gennimatas”, Thessaloniki, Greece ; Anastasakis, Michalis : First Department of Pediatric Surgery, Aristotle University of Thessaloniki Greece, General Hospital “G.Gennimatas”, Thessaloniki, Greece ; Psarrakou, Ioanna Sofia : Department of Pediatrics, General Hospital “G. Gennimatas”, Thessaloniki, Greece ; Patoulias, Ioannis : First Department of Pediatric Surgery, Aristotle University of Thessaloniki Greece, General Hospital “G.Gennimatas”, Thessaloniki, GreeceAuthors
Keywords
Balanitis Xerotica Obliterans ; Lichen Sclerosus ; meatitis ; phimosis ; circumcisionDivisions of PAS
Nauki MedyczneCoverage
93-100Publisher
Oddział PAN w Krakowie; Uniwersytet Jagielloński – Collegium MedicumBibliography
1. Hartley A., Ramanathan C., Siddiqui H.: The surgical treatment of Balanitis Xerotica Obliterans. Indian J Plast Surg. 2011 Jan; 44 (1): 91–97.2. Depasquale I., Park A.J., Bracka A.: The treatment of balanitis xerotica obliterans. BJU International. 2000; 86 (4): 459–465.
3. Singh I., Ansari M.S.: Extensive Balanitis Xerotica Obliterans (BXO) involving the anterior urethra and scrotum. Int Urol Nephrol. 2006; 38: 505–506.
4. Hallopeau H.: Leçons cliniques sur les maladies cutanées et syphiliques. Union Med Can. 1887; 43: 472.
5. Depasquale I., Park A.J., Bracka A.: The treatment of Balanitis Xerotica obliterans. BJU Int 2000; 86: 459–465.
6. Catterall R.D., Oates J.K.: Treatment of Balanitis Xerotica obliterans with hydrocortisone injections. Br J Vener Dis. 1962; 38: 75–77.
7. Becker K.: Lichen Sclerosus in Boys. Dtsch Arztebl Int. 2011; 108 (4): 53–58.
8. Kizer W.S., Prarie T., Morey A.F.: Balanitis xerotica obliterans: Epidemiologic distribution in an equal access health care system. South Med J. 2003; 96: 9–11.
9. Jayakumar S., Antao B., Bevington O., Furness P., Ninan G.K.: Balanitis Xerotica obliterans in children and its incidence under the age of 5 years. J Ped Urol 2012; 8: 272–275.
10. Bochove-Overgaauw D., Gelders W., De Vyider A.: Rutine biopsies in pediatric circumcision (non) sense? J Pediatr Urol. 2009; 5: 178–180.
11. Pilatz A., Altinkilic B., Schormann E., et al.: Congenital phimosis in patients with and without lichen sclerosus: distinct expression patterns of tissue remodeling associated genes. J Uro. 2013; 189: 268e74.
12. Kizer W.S., Prarie T., Morey A.F.: Balanitis Xerotica Obliterans: epidemiologic distribution in an equal access health care system. South Med J. 2003; 96: 9e11.
13. Ebert A.K., Rösch W.H., Vogt T.: Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol. 2008; 54: 932e7.
14. Gargollo P., Kozakewich H., Bauer S., et al.: Balanitis Xerotica obliterans in boys. J Urol 2005; 174: 1409e12.
15. Kiss A., Csontai A., Pirot L., Nyirady P., Merksz M., Kiraly L.: The response of Balanitis Xerotica obliterans to local, steroid application compared with placebo in children. J Urol 2001; 165: 219e20.
16. Powell J., Wojnarowska F.: Lichen sclerosus. 1999; 353: 1777e89.
17. Peterson A.C., Palmineteri E., Lazzeri M., Guanzoni G., Barbagli G., Webster G.: Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (Balanitis Xerotica obliterans). J Urol. 2004; 64: 565–568.
18. Dillon W.I., Saeed G.M., Fivenson D.P.: Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphoea, scleroderma or lichen sclerosus et atrophicus inpatients of North America. J Am AcadDermatol. 1995; 33: 617e20.
19. Pugliese J., Morey A., Peterson A.: Lichen sclerosus: review of the literature and current recommendations for management. J Urol. 2007; 178: 2268e76.
20. Meffert J.J., Davis B.M., Grimwood R.E.: Lichen sclerosus. J Am Acad Dermatol. 1995; 32: 393–416.
21. Powell J., Wojnarowska F.: Childhood vuvlvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol. 2001; 44: 803–806.
22. Depasquale I., Park A.J., Singh I., Ansari M.S.: Extensive Balanitis Xerotica Obliterans (BXO) involving the anterior urethra and scrotum. In Urol Nephrol. 2006; 38: 505–506.
23. Yardiey I.E., Cosgrove C., Lambert A.W.: Pediatric preputial pathology: are we circumcising enough? Ann R Coll Surg Engl. 2007; 89: 62–65.
24. Edmonds E., Barton G., Buisson S., et al.: Gene expression profiling in male genital lichen sclerosus. Int J ExpPathol. 2011; 92: 320e5.
25. Bale P.M., Lochhead A., Martin H.C., Gollow I.: Balanitis xerotica obliteransin children. Pediatr Pathol. 1987; 7: 617–627.
26. Mattioli G., Repetto P., Carlini C., Granata C., Gambini C., Jasonni V.: Lichen sclerosus et atrophicus in children with phimosis and hypospadias. Pediatr Surg Int. 2002; 18: 273e5.
27. Batbagli G., Palminteri E., Balo S., et al.: Lichen sclerosus of the male genitalia and urethral stricture diseases. Urol Int. 2004; 73: 1–5.
28. Celis S., Reed F., Murphy F., et al.: Balanitis xerotica obliteransin in children and adolescents: A literature review and clinical series. J Pediatr Urol. 2014; 10: 34–39.
29. Kiss A., Király L., Kutasy B., Merksz M.: High incidence of Balanitis Xerotica Obliterans in boys with phimosis: prospective 10-year study. Ped Dermatol. 2005; 22: 305–308.
30. Bale P.M., Lochhead A., Martin H.C., et al.: BXO in children Pediatr Pathol. 1987; 7: 617; 9.
31. Mohammed A., Shegil I.S., Christou D., Khan A., Barua J.M.: Paediatric Balanitis Xerotica obliterans: an 8-year experience. Arch Ital Urol Androl. 2012; 84: 12e6.
32. Vincent M., MacKinnon E.: The response of clinical Balanitis Xerotica Obliterans to the application of topical steroid-based creams. J Pediatr Surg. 2005; 40: 709e12.
33. Holbrook C., Tsang T.: Management of boys with abnormal appearance of meatus at circumcision for BXO. Ann R Coll Surg Engl. 2011; 93: 482–484.
34. Barbagli G., Palminteri E., Baló S., et al.: Lichen sclerosus of the male genitalia and urethral stricture deseases. Urol Int. 2004; 73: 1–5.
35. Pugliese J., Morey A., Peterson A.: Lichen sclerosus: review ofthe literature and current recommendations for management. J Urol. 2007; 178: 2268e76.
36. Nasca M.R., Innocenzi D., Micali G.: Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. 1999; 41: 911e4.
37. Pietrzak P., Hadway P., Corbishley C., Watkin N.: Is the association between Balanitis Xerotica Obliterans and penile carcinoma underestimated? BJU Int. 2006; 98: 74e6.
38. Prowse D.M., Ktori E.N., Chandrasekaran D., et al.: Human papillomavirus-associated increase in p16-INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol. 2008; 158: 261–265.
39. Neill S.M., Tatnall F.M., Cox N.H.: Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002; 147: 640–649.
40. Poindexter G., Morrell D.S.: Anogenital pruritus: lichen sclerosus in children. Pediatr Ann. 2007; 36: 785–791.